[Risk of inducing resistance upon stopping and restarting lithium after long-term usage].
Collumbien
E C
EC
D000328:Adult; D018692:Antimanic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000188:drug therapy* / Q000209:etiology*; D003937:Diagnosis, Differential; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D006961:Hyperparathyroidism / Q000150:complications* / Q000175:diagnosis* / Q000601:surgery; D008094:Lithium / Q000008:administration & dosage / Q000627:therapeutic use*; D016105:Parathyroidectomy / Q000379:methods; D055502:Secondary Prevention; D016896:Treatment Outcome
D018692:Antimanic Agents; D008094:Lithium
Het risico van lithiumresistentie na stoppen en herstart na langdurig gebruik.